Clinical aspects of ECL-cell abnormalities

Authors
Citation
Bi. Hirschowitz, Clinical aspects of ECL-cell abnormalities, YALE J BIOL, 71(3-4), 1998, pp. 303-310
Citations number
65
Categorie Soggetti
Medical Research General Topics
Journal title
YALE JOURNAL OF BIOLOGY AND MEDICINE
ISSN journal
00440086 → ACNP
Volume
71
Issue
3-4
Year of publication
1998
Pages
303 - 310
Database
ISI
SICI code
0044-0086(199805/08)71:3-4<303:CAOEA>2.0.ZU;2-I
Abstract
ECL cell hyperplasia results from hypergastrinemia, and in man this occurs due to achlorhydria in atrophic gastritis (pernicious anemia [PA]) and gast rinoma (Zollinger-Ellison syndrome [ZES]). Progression to neoplasia, i.e., ECL cell carcinoids (usually small, multicentric and non-functional), occur s in some five to 10 percent of patients with PA where they remain gastrin- dependent and reversible by normalization of serum gastrin by antrectomy. E ven if untreated, the carcinoids are almost invariably benign and do not ca use death. In ZES, ECL cell hyperplasia is progressive due to hypergastrine mia. However, carcinoids develop only in the MEN-I subtype but pose no addi tional threat of malignancy. A conservative approach is recommended for sma ll multicentric carcinoids, and the tumors do not need removal. By contrast , single, large, non-gastrin-dependent carcinoids represent a different bio logical and clinical problem and are frequently malignant.